Top Section/Ad
Top Section/Ad
Most recent
French biotech seeks to accelerate cancer vaccine program
Payment processor's shares dropped to new low on Thursday
More articles/Ad
More articles/Ad
More articles
-
Cobham, the UK aerospace and marine technology company, has finished its second rights issue in 12 months, after the leads completed a small rump placement. -
A senior ECM banker in Malaysia has left RHB Investment Bank to join AmInvestment Bank, taking on a broader role encompassing ECM as well as the entire equities franchise.
-
Quam Financial Services Group, an arm of Mainland conglomerate China Oceanwide Holdings, is seeking shareholder approval for a HK$5.1bn ($659.8m) rights issue.
-
Shareholders of Sarana Menara Nusantara raised Rph5.4tr ($405.2m) from a re-IPO of the Indonesian company, selling the stock at the bottom of indications.
-
Shares in Lonza, the Swiss pharmaceutical company, closed 3.8% higher on Wednesday after it launched its Sfr2.25bn rights issue to partly finance its acquisition of Capsugel from KKR, having secured approval from its shareholders at its annual general meeting on Tuesday.
-
Credit Suisse shares closed 2.7% higher on Wednesday after the bank confirmed what had been widely expected: it will conduct its second rights issue in 18 months, and scrap its plan to float its Swiss Universal Bank.
